November 18, 2024
TOPLINE: Supplementation with vitamin D and calcium can reduce systolic and diastolic blood pressure in older individuals with overweight, particularly in those with a body mass […]
November 18, 2024
(Reuters) – U.S. government health plans account for the lion’s share of coverage for popular new weight-loss drugs, far beyond the reimbursement available from private employers […]
November 15, 2024
TOPLINE: Since 1990, the largest increase in diabetes prevalence has occurred in low-income and middle-income countries, whereas improvements in treatment have been greatest in high-income and […]
November 15, 2024
VANCOUVER, British Columbia — Conditions like diabetes and dementia are common in patients who are admitted to long-term care facilities, but aggressive management of these conditions […]
November 14, 2024
LONDON (Reuters) -Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its […]
November 14, 2024
The decision to prescribe a compounded or brand-name glucagon-like peptide 1 (GLP-1) medication for obesity treatment was never simple, but recent developments have complicated it further. […]
November 14, 2024
CHICAGO — New research is illuminating the long-term health consequences faced by patients with thyroid cancer in areas related to fertility, bone health, and cardiovascular disease. […]
November 14, 2024
SAN ANTONIO — Semaglutide 2.4 mg (Wegovy) was associated with a 22% reduction in annual medical costs in people with overweight/obesity and heart failure, new research […]
November 13, 2024
(Reuters) -Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding […]